A randomised controlled trial of feedback to general practitioners of their prophylactic aspirin prescribing

British Medical Journal

Volumn 315, Issue 7099, 1997, Pages 35-36

  McCartney, Peter ^a   Macdowall, Wendy ^a   Thorogood, Margaret ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; ESTROGEN THERAPY; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

EID: 0030981073     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7099.35     Document Type: Article

References (4)

1. King R, Denne J. Audit suggests that use of aspirin in coronary heart disease is rising. BMJ 1995;311:1504.
2. Aspirin to prevent heart attack or stroke. Drug Ther Bull 1994;32:1-3.
3. NHS Centre for Reviews and Dissemination. Aspirin and myocardial infarction. Effectiveness Matters 1995;1(1).
4. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: fourth national study 1991-2. London: HMSO, 1995. (Series MB5, No 3.)